Literature DB >> 6538354

Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis.

A J Furlan, A R Craciun, N R Raju, N Hart.   

Abstract

One hundred fifty patients with idiopathic hypertrophic subaortic stenosis (IHSS) were followed-up for an average of 5.5 years. There were 95 males and 55 females with a mean age of 51 years. Patients usually presented with cardiac symptoms or syncope; no patient presented with stroke. Eight patients (5%) died during follow-up, all from cardiac causes. Eleven patients (7%) developed cerebrovascular complications; 5 (3%) had a stroke and 6 (4%) had TIA only. Patients with IHSS and atrial fibrillation have a much greater stroke risk. Mitral annulus calcification may also increase stroke risk in IHSS. However, stroke is almost never the presenting manifestation of IHSS, and the longterm risk of stroke for most patients with known IHSS is low.

Entities:  

Mesh:

Year:  1984        PMID: 6538354     DOI: 10.1161/01.str.15.2.282

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

2.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 3.  Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Authors:  I Olivotto; B J Maron; F Cecchi
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

Review 4.  Thromboembolism in Patients with Hypertrophic Cardiomyopathy.

Authors:  Lu Liu; Zheng Liu; Xiaoping Chen; Sen He
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

5.  Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy.

Authors:  Junya Komatsu; Ryu-Ichiro Imai; Yoko Nakaoka; Koji Nishida; Shu-Ichi Seki; Toru Kubo; Naohito Yamasaki; Hiroaki Kitaoka; Sho-Ichi Kubokawa; Kazuya Kawai; Naohisa Hamashige; Yoshinori L Doi
Journal:  Circ Rep       Date:  2021-04-06

Review 6.  Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually.

Authors:  Xiaogang Zhu; Zhenhua Wang; Markus W Ferrari; Katharina Ferrari-Kuehne; Javed Bulter; Xiuying Xu; Quanzhong Zhou; Yuhui Zhang; Jian Zhang
Journal:  ESC Heart Fail       Date:  2021-09-08

7.  CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Authors:  Theano Papavassiliu; Tjeerd Germans; Stephan Flüchter; Christina Doesch; Anton Suriyakamar; Dariusch Haghi; Tim Süselbeck; Christian Wolpert; Dietmar Dinter; Stefan O Schoenberg; Albert C van Rossum; Martin Borggrefe
Journal:  J Cardiovasc Magn Reson       Date:  2009-09-09       Impact factor: 5.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.